bcr_patient_barcode	type	age_at_initial_pathologic_diagnosis	gender	race	clinical_stage	histological_type	menopause_status	tumor_status	new_tumor_event_type	treatment_outcome_first_course	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time
TCGA-N5-A4R8	UCS	65	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	Complete_Remission/Response	1	3115	NA	3115	0	3115	0	3115
TCGA-N5-A4RA	UCS	63	FEMALE	WHITE	Stage_IIIC2	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	1	1591	NA	1591	NA	NA	0	1591
TCGA-N5-A4RD	UCS	69	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	142	1	142	NA	NA	1	75
TCGA-N5-A4RF	UCS	68	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1806	0	1806	0	1806	0	1806
TCGA-N5-A4RJ	UCS	61	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	550	1	550	NA	NA	1	287
TCGA-N5-A4RM	UCS	62	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	148	1	148	NA	NA	1	144
TCGA-N5-A4RN	UCS	71	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	1053	0	1053	NA	NA	1	570
TCGA-N5-A4RO	UCS	67	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC2	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	Progressive_Disease	1	685	1	685	NA	NA	1	407
TCGA-N5-A4RS	UCS	65	FEMALE	WHITE	Stage_IB	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	911	1	911	1	427	1	427
TCGA-N5-A4RT	UCS	69	FEMALE	WHITE	Stage_IIIC1	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2485	0	2485	0	2485	0	2485
TCGA-N5-A4RU	UCS	54	FEMALE	WHITE	Stage_IIIC2	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	1526	1	1526	1	253	1	253
TCGA-N5-A4RV	UCS	62	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2042	0	2042	0	2042	0	2042
TCGA-N5-A59E	UCS	62	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	447	1	447	NA	NA	1	354
TCGA-N5-A59F	UCS	65	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	361	1	361	1	274	1	274
TCGA-N6-A4V9	UCS	59	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	979	0	979	0	979	0	979
TCGA-N6-A4VC	UCS	83	FEMALE	WHITE	Stage_III	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	597	1	597	NA	NA	1	171
TCGA-N6-A4VD	UCS	81	FEMALE	WHITE	Stage_IIIA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	112	1	112	NA	NA	1	49
TCGA-N6-A4VE	UCS	84	FEMALE	WHITE	Stage_IIIC	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	291	1	291	NA	NA	1	275
TCGA-N6-A4VF	UCS	51	FEMALE	WHITE	Stage_IB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	NA	1	522	0	522	NA	NA	0	522
TCGA-N6-A4VG	UCS	77	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Partial_Remission/Response	0	1574	0	1574	NA	NA	1	493
TCGA-N7-A4Y0	UCS	65	FEMALE	WHITE	Stage_IIIC	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	NA	1	771	1	771	NA	NA	1	281
TCGA-N7-A4Y5	UCS	87	FEMALE	WHITE	Stage_IIB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	8	1	8	NA	NA	1	8
TCGA-N7-A4Y8	UCS	72	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	Partial_Remission/Response	1	378	1	378	NA	NA	1	187
TCGA-N7-A59B	UCS	69	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	827	0	827	0	827	0	827
TCGA-N8-A4PI	UCS	71	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Partial_Remission/Response	1	810	1	810	NA	NA	1	255
TCGA-N8-A4PL	UCS	82	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	418	1	418	NA	NA	1	138
TCGA-N8-A4PM	UCS	73	FEMALE	WHITE	Stage_IB	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	829	0	829	1	524	1	524
TCGA-N8-A4PN	UCS	68	FEMALE	WHITE	Stage_IIIC1	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	812	0	812	0	812	0	812
TCGA-N8-A4PO	UCS	66	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	0	781	0	781	NA	NA	1	158
TCGA-N8-A4PP	UCS	88	FEMALE	WHITE	Stage_IIIC1	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Partial_Remission/Response	1	611	1	611	NA	NA	1	149
TCGA-N8-A4PQ	UCS	76	FEMALE	WHITE	Stage_IIIC2	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	572	0	572	0	572	0	572
TCGA-N8-A56S	UCS	75	FEMALE	WHITE	Stage_IB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	Stable_Disease	1	371	1	371	NA	NA	1	199
TCGA-N9-A4PZ	UCS	77	FEMALE	WHITE	Stage_IIIC2	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	667	1	667	1	487	1	487
TCGA-N9-A4Q1	UCS	70	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	2043	1	2043	1	1839	1	1839
TCGA-N9-A4Q3	UCS	65	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	1672	0	1672	1	735	1	735
TCGA-N9-A4Q4	UCS	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	Complete_Remission/Response	0	1089	0	1089	0	1089	0	1089
TCGA-N9-A4Q7	UCS	69	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	604	0	604	0	604	0	604
TCGA-N9-A4Q8	UCS	68	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	481	1	481	1	215	1	215
TCGA-NA-A4QV	UCS	72	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	4269	0	4269	0	4269	0	4269
TCGA-NA-A4QW	UCS	61	FEMALE	WHITE	Stage_IIA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2457	0	2457	0	2457	0	2457
TCGA-NA-A4QX	UCS	60	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	NA	1	838	1	838	NA	NA	1	566
TCGA-NA-A4QY	UCS	62	FEMALE	WHITE	Stage_III	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	114	1	114	NA	NA	1	114
TCGA-NA-A4R0	UCS	80	FEMALE	WHITE	Stage_IVB	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	541	1	541	NA	NA	1	541
TCGA-NA-A4R1	UCS	75	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC1	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	203	1	203	NA	NA	1	203
TCGA-NA-A5I1	UCS	80	FEMALE	WHITE	Stage_IIIB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	NA	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	2680	1	2680	1	2553	1	2553
TCGA-ND-A4W6	UCS	67	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	317	1	317	NA	NA	1	317
TCGA-ND-A4WA	UCS	90	FEMALE	ASIAN	Stage_IC	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	714	0	714	0	714	0	714
TCGA-ND-A4WC	UCS	83	FEMALE	ASIAN	Stage_IB	Uterine_Carcinosarcoma/MMMT:_Homologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	766	0	766	0	766	0	766
TCGA-ND-A4WF	UCS	77	FEMALE	WHITE	Stage_IIIA	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	167	1	167	NA	NA	1	167
TCGA-NF-A4WU	UCS	59	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	298	0	298	0	298	0	298
TCGA-NF-A4WX	UCS	61	FEMALE	NA	Stage_IV	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	452	0	452	NA	NA	0	452
TCGA-NF-A4X2	UCS	59	FEMALE	WHITE	Stage_II	Uterine_Carcinosarcoma/_MMMT:_Heterologous_Type	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	81	0	81	0	81	0	81
TCGA-NF-A5CP	UCS	90	FEMALE	WHITE	Stage_IIIC2	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	Progressive_Disease	1	167	1	167	NA	NA	1	106
TCGA-NG-A4VU	UCS	63	FEMALE	WHITE	Stage_IIIB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Progression_of_Disease	Progressive_Disease	1	442	1	442	NA	NA	1	281
TCGA-NG-A4VW	UCS	74	FEMALE	WHITE	Stage_IC	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	949	1	949	1	937	1	937
TCGA-QM-A5NM	UCS	67	FEMALE	WHITE	Stage_IA	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	NA	0	587	0	587	NA	NA	1	153
TCGA-QN-A5NN	UCS	55	FEMALE	ASIAN	Stage_IB	Uterine_Carcinosarcoma/_Malignant_Mixed_Mullerian_Tumor_(MMMT):_NOS	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	0	0	0	0	0	0	0
